Bumper Offer - Urjas oil Just @ Rs. 1
Respillin is a prescription medicine that is available as a Syrup. Cough are some of its major therapeutic uses. Respillin also has some secondary and off-label uses. These are listed below.
The correct dosage of Respillin depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Respillin are Headache, Muscle cramps or spasms (painful), Unsteadiness. Normally, these side effects of Respillin are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Respillin's effect during pregnancy is Unknown and Unknown while nursing. It is important to know if Respillin has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Respillin related warnings section.
Other contraindications of Respillin have been discussed in the sections ahead.
Drug interactions for Respillin have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Respillin, it is important to know that it is not safe while driving, and is not habit-forming.
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Respillin is used -
Common
Is the use of Respillin safe for pregnant women?
No research has not been done till date on the safety of Respillin for pregnant women. So its effects on pregnant women are unknown.
Is the use of Respillin safe during breastfeeding?
Information about safety of Respillin for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Respillin on the Kidneys?
Respillin is completely safe for kidneys.
What is the effect of Respillin on the Liver?
Respillin is not harmful for the liver.
What is the effect of Respillin on the Heart?
Respillin may have mild side effects on the heart. Most people will never see any effect on the heart.
Respillin should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Respillin unless your doctor advises you to do so -
Is this Respillin habit forming or addictive?
Forming a habit of Respillin has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Respillin, you should not drive or work on any heavy machine, as Respillin can make you drowsy.
Is it safe?
Respillin should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Respillin is not used to treat mental disorders.
Interaction between Food and Respillin
Taking Respillin with food does not harm your health.
Interaction between Alcohol and Respillin
Consumption of alcohol and Respillin together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Proventil® HFA (albuterol sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 118-120
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
Product Description [Internet]: National Pharmaceutical Regulatory Agency (NPRA)
Product Description [Internet]: BENYLIN. McNeil
Package Leaflet [Internet]: SALBUTAMOL. Orion Corporation
Package Leaflet [Internet]: SALBUTAMOL. Pinewood Laboratories Ltd
